Douglas Lane & Associates, LLC Moderna, Inc. Transaction History

Douglas Lane & Associates, LLC

$6.9 Billion
Q4 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 773,804 shares of MRNA stock, worth $25.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

773,804

Previous 475,089 62.88%

Holding current value

$25.2 Million

Previous $31.8 Million 1.34%

% of portfolio

0.47%

Previous 0.45%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 08, 2025	BUY	$36.85 - $63.93 $11 Million - $19.1 Million	298,715 Added 62.88%	773,804 $32.2 Million
Q3 2024 Oct 10, 2024	BUY	$63.64 - $125.14 $4.51 Million - $8.87 Million	70,889 Added 17.54%	475,089 $31.8 Million
Q2 2024 Jul 08, 2024	BUY	$101.21 - $166.61 $1.13 Million - $1.86 Million	11,161 Added 2.84%	404,200 $48 Million
Q1 2024 Apr 11, 2024	BUY	$85.37 - $115.44 $4.86 Million - $6.57 Million	56,901 Added 16.93%	393,039 $41.9 Million
Q4 2023 Jan 17, 2024	SELL	$69.51 - $104.43 $1.32 Million - $1.99 Million	-19,039 Reduced 5.36%	336,138 $33.4 Million
Q3 2023 Oct 16, 2023	BUY	$96.41 - $126.61 $9.14 Million - $12 Million	94,810 Added 36.41%	355,177 $36.7 Million
Q2 2023 Jul 19, 2023	BUY	$118.5 - $160.53 $6.4 Million - $8.67 Million	54,034 Added 26.19%	260,367 $31.6 Million
Q1 2023 Apr 17, 2023	BUY	$135.66 - $197.02 $2.5 Million - $3.63 Million	18,408 Added 9.8%	206,333 $31.7 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $16,573 - $29,405	-140 Reduced 0.07%	187,925 $33.8 Million
Q4 2022 Jan 17, 2023	BUY	$118.38 - $210.04 $5.39 Million - $9.57 Million	45,572 Added 31.98%	188,065 $33.8 Million
Q3 2022 Oct 14, 2022	BUY	$118.07 - $194.18 $3.44 Million - $5.66 Million	29,131 Added 25.7%	142,493 $16.9 Million
Q2 2022 Jul 18, 2022	BUY	$117.13 - $176.59 $4.81 Million - $7.25 Million	41,081 Added 56.84%	113,362 $16.2 Million
Q1 2022 Apr 25, 2022	BUY	$126.46 - $235.05 $6.19 Million - $11.5 Million	48,917 Added 209.37%	72,281 $12.5 Million
Q4 2021 Jan 25, 2022	BUY	$225.82 - $368.51 $1.45 Million - $2.36 Million	6,407 Added 37.78%	23,364 $5.93 Million
Q3 2021 Oct 21, 2021	BUY	$221.9 - $484.47 $1.42 Million - $3.11 Million	6,421 Added 60.94%	16,957 $6.53 Million
Q2 2021 Jul 19, 2021	BUY	$129.91 - $234.98 $1.37 Million - $2.48 Million	10,536 New	10,536 $2.48 Million

Others Institutions Holding MRNA

# of Institutions

909

Shares Held

235M

Call Options Held

10.6M

Put Options Held

18.6M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Moderna, Inc. Transaction History